Caregiver burden and health in bipolar disorder: a cluster analytic approach.

Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10019, USA.
The Journal of nervous and mental disease (Impact Factor: 1.81). 06/2008; 196(6):484-91. DOI: 10.1097/NMD.0b013e3181773927
Source: PubMed

ABSTRACT To identify caregivers at risk for adverse health effects associated with caregiving, the stress, coping, health and service use of 500 primary caregivers of patients with bipolar disorder were assessed at baseline, 6, and 12 months. K-means cluster analysis and ANOVA identified and characterized groups with differing baseline stress/coping profiles. Mixed effects models examined the effects of cluster, time, and covariates on health outcomes. Three groups were identified. Burdened caregivers had higher burden and avoidance coping levels, and lower mastery and social support than effective and stigmatized caregivers; stigmatized caregivers reported the highest perceived stigma (p < 0.05). Effective and stigmatized groups had better health outcomes and less service use than the burdened group over time; stigmatized caregivers had poorer self-care than effective caregivers. Cluster analysis is a promising method for identifying subgroups of caregivers with different stress and coping profiles associated with different health-related outcomes.

Download full-text


Available from: Deborah Perlick, Nov 20, 2014
  • Source
    Clinical, Research and Treatment Approaches to Affective Disorders, 02/2012; , ISBN: 978-953-51-0177-2
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The burden experienced by caregivers of patients with bipolar disorder has been associated with increased caregiver depression, anxiety and mental health service use. As caregiver burden is also associated with poor patient outcome, these findings may indicate a source of distress not only for caregivers, but also for patients. This review presents what is currently known about psychiatric symptoms in this population and suggests directions for future research. Computerized databases Medline, Pubmed, PsychINFO and Google Scholar were searched using the keywords 'bipolar disorder', 'manic-depressive disorder', 'caregiver', 'caregiver burden', 'family', 'couple', 'spouse' and 'partner.' Of these, publications both measuring and reporting psychiatric symptoms or mental health service use in adult caregivers were included. Twenty four (24) papers were analyzed. Thirteen (13) of these papers measured general psychiatric distress, 2 measured anxiety symptoms, 9 reported mood symptoms and 8 reported increased mental health service use. 21 total papers reported clinical significance of least one category of psychiatric distress. Significant findings include up to 46% of caregivers reporting depression and up to 32.4% reporting mental health service use. Data suggest that caregiver psychiatric symptoms depend on the nature of the caregiving relationship. Common methodological problems included: lack of control groups, small sample sizes and non-standardized caregiver and patient criteria. While not all of the data are consistent, the majority of papers report the presence of psychiatric symptoms in caregivers, such as depression, anxiety and increased mental health service use. Future research is needed to address methodological issues and focus on distinguishing symptoms and identifying effects of mediators such as caregiver-patient relationship, coping styles and stigma. Interventions tailored towards the psychiatric needs of bipolar families may result in improved caregiver and patient outcomes, as well as in decreased health care costs.
    Journal of Affective Disorders 06/2009; 121(1-2):10-21. DOI:10.1016/j.jad.2009.04.020 · 3.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study evaluated the effectiveness of first- and second-generation antipsychotics in reducing family burden associated with schizophrenia. The family caregivers of 623 SCID-diagnosed patients enrolled in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) randomly assigned to a first-generation antipsychotic (perphenazine) or one of four second-generation drugs (olanzapine, quetiapine, risperidone or ziprasidone) were interviewed about resources provided and stresses experienced at baseline and followed for 18 months. Patient symptoms, side effects and service use were assessed as well. Hierarchical regression analyses evaluated the effect of treatment assignment on four burden factors: problem behavior, resource demands and disruption, impairment in activities of daily living and patient helpfulness. Intention-to-treat analyses with all available observations classified based on initial treatment assignment, including observations after medications changed were followed by secondary analyses excluding observations after the first medication change, i.e. only considering initial medication. Despite significant reductions on the problem behavior and resource demands/disruption factors, there were no significant differences between perphenazine and any of the second-generation medications. When only initial treatment period observations were included, patients were perceived as more helpful when medicated with perphenazine as compared to risperidone. In comparisons between second-generation drugs, patients on quetiapine were perceived as more helpful than those on risperidone (p=0.004). In this 18-month randomized trial, there was no evidence of superiority of second-generation antipsychotics in relieving family burden.
    Schizophrenia Research 10/2009; 116(2-3):118-25. DOI:10.1016/j.schres.2009.09.026 · 4.43 Impact Factor